Monoethanolamine Market Report 2026

The monoethanolamine market size has grown strongly in recent years. It will grow from $3.46 billion in 2025 to $3.69 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to natural gas processing growth, detergent manufacturing expansion, chemical industry development, refinery capacity increase, infrastructure construction demand.

The monoethanolamine market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to carbon capture initiatives, gas processing investments, construction sector growth, specialty chemical demand, industrial efficiency improvements. Major trends in the forecast period include growing use in gas sweetening processes, rising demand from detergents and cleaners, expansion of chemical intermediate applications, increased adoption in cement and construction additives, focus on high purity industrial grades.

The increasing application in the pharmaceutical industry is expected to drive the growth of the monoethanolamine market in the coming years. The pharmaceutical industry is a sector focused on the research, development, manufacturing, and marketing of drugs and medications to improve health and treat diseases. The pharmaceutical industry is expanding due to rising demand for advanced treatments and medicines, the growing prevalence of chronic diseases, and continuous innovations in drug development. Monoethanolamine is used in the pharmaceutical industry as a key component in the synthesis of various drugs, serving as a building block for the production of active pharmaceutical ingredients and formulations. For instance, in April 2024, according to Eurostat, a Luxembourg-based official statistical agency of the European Union, imports of medicinal and pharmaceutical products into the EU rose by 6.1% in 2023, totaling US$128.9 billion (€119 billion) compared to the previous year. During the same period, EU exports reached US$299.9 billion (€277 billion), resulting in a trade surplus of US$171 billion (€158 billion). Therefore, the growing application in the pharmaceutical industry is driving the growth of the monoethanolamine market.

Leading companies in the monoethanolamine market are increasingly forming strategic partnerships to broaden their amine product portfolios. These collaborations involve combining resources, expertise, and capabilities to achieve shared business objectives and gain competitive advantages. For example, in February 2024, BASF SE, a Germany-based manufacturer of monoethanolamine, entered into a partnership with OQEMA AG, a German chemical distributor. Through this alliance, OQEMA will utilize its extensive distribution network and in-depth knowledge of the UK market, while BASF will offer high-quality, competitively priced products on a large scale, thereby enhancing their collective market presence.

In December 2023, Ineos Group Limited, a UK-based chemicals company, acquired the Eastman Texas City Site for an undisclosed amount. This acquisition supports INEOS's global strategy for its acetyls business and will involve integrating the site, business, and employees into INEOS Acetyls. Eastman Chemical, based in the US, is a manufacturer of monoethanolamine products.

Major companies operating in the monoethanolamine market are BASF SE, Dow Inc., SABIC, Sasol Limited, INEOS Group, Huntsman Corporation, Eastman Chemical Company, Mitsui Chemicals, Lotte Chemical, Petronas Chemicals Group, Nouryon, Zhejiang Jianye Chemical, Alkyl Amines Chemicals Limited, Amines & Plasticizers Limited, Balaji Amines Limited, Sintez OKA Group, Jiahua Chemicals, Shijiazhuang Jinjin Chemical, OUCC (Oriental Union Chemical Corporation), Yantai Shida Chemical.

Asia-Pacific was the largest region in the monoethanolamine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monoethanolamine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the monoethanolamine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The monoethanolamine market consists of sales of emulsifiers, gas treatment chemicals, pharmaceutical intermediates and water treatment chemicals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.